• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者的抗凝管理。

Anticoagulant management in patients with atrial fibrillation.

机构信息

University of Birmingham, Birmingham, United Kingdom.

出版信息

Semin Thromb Hemost. 2009 Sep;35(6):543-7. doi: 10.1055/s-0029-1240014. Epub 2009 Sep 28.

DOI:10.1055/s-0029-1240014
PMID:19787557
Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of embolic stroke (cause in 15% of all strokes and 30% of strokes in those >75 years of age). Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoagulation, namely bleeding, can be minimized by maintaining anticoagulation control within the international normalized range range of 2.0 to 3.0 (target: 2.5). To have a public health impact, patients with AF need efficient and correct identification, with appropriate treatment directed at those patients at most risk from the condition.

摘要

心房颤动(AF)是最常见的心律失常,与栓塞性中风(所有中风的 15%和 75 岁以上中风的 30%)的风险较高有关。华法林抗凝可将中风风险降低约三分之二。抗凝的主要风险,即出血,可以通过将抗凝控制维持在国际标准化比值 2.0 至 3.0 的范围内(目标:2.5)来最小化。为了产生公共卫生影响,需要有效地识别出 AF 患者,并对处于最高风险的患者进行适当的治疗。

相似文献

1
Anticoagulant management in patients with atrial fibrillation.心房颤动患者的抗凝管理。
Semin Thromb Hemost. 2009 Sep;35(6):543-7. doi: 10.1055/s-0029-1240014. Epub 2009 Sep 28.
2
Pharmacoeconomics of atrial fibrillation and stroke prevention.心房颤动与中风预防的药物经济学
Am J Manag Care. 2004 Apr;10(3 Suppl):S66-71.
3
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.影响心房颤动患者抗凝治疗期间出血风险的因素:来自节律管理心房颤动随访调查(AFFIRM)研究的观察结果
Am Heart J. 2005 Apr;149(4):650-6. doi: 10.1016/j.ahj.2004.11.015.
4
Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.老年房颤患者(包括有跌倒和/或早期痴呆症的患者)预防卒中的抗凝治疗:一项单中心、回顾性、观察性研究。
Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.
5
Stroke prevention in elderly patients with atrial fibrillation.老年房颤患者的卒中预防
Singapore Med J. 2002 Apr;43(4):198-201.
6
Anticoagulation: stroke prevention in patients with atrial fibrillation.抗凝治疗:心房颤动患者的卒中预防
Med Clin North Am. 2008 Jan;92(1):143-59, xi. doi: 10.1016/j.mcna.2007.08.007.
7
[Atrial fibrillation and thromboembolic events prevention. State of the art].[心房颤动与血栓栓塞事件的预防。最新进展]
Minerva Cardioangiol. 2001 Feb;49(1):1-13.
8
Anticoagulation and atrial fibrillation.抗凝与心房颤动
Herz. 1993 Feb;18(1):27-38.
9
Antithrombotic therapies for stroke prevention in atrial fibrillation.用于心房颤动中风预防的抗栓治疗
Minerva Cardioangiol. 2004 Apr;52(2):125-39.
10
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.患有心房颤动且中风风险高的住院患者未得到充分的抗凝治疗。
J Am Coll Cardiol. 2005 Nov 1;46(9):1729-36. doi: 10.1016/j.jacc.2005.06.077. Epub 2005 Oct 10.